Posts With Tag RNA interference

Showing 1 - 2 of 2 Posts

$BNTC

•

10-Q

•

2025-02-14

Last updated: about 1 year ago

Benitec Biopharma Inc. (BNTC) Q4 2024 Financial Report: Insights & Future Strategies

Explore Benitec Biopharma's Q4 2024 financial performance, key metrics, and strategic outlook amid ongoing losses and R&D investments.

Biotechnology Gene Therapy RNA Interference Financial Analysis Investment Strategy

Arrowhead Pharmaceuticals Q4 2024 Financial Report: Losses & Promising Collaborations

$ARWR

•

10-Q

•

2025-02-10

Last updated: about 1 year ago

Arrowhead Pharmaceuticals Q4 2024 Financial Report: Losses & Promising Collaborations

Explore Arrowhead Pharmaceuticals' Q4 2024 report highlighting a $173.1M net loss, $578.3M in securities, and strategic partnerships worth up to $14.1B. Investment recommendation: Hold.

Biopharmaceuticals RNA interference Clinical trials Investment analysis Collaboration agreements